Preventing breast cancer in LMICs via screening and/or early detection: The real and the surreal

World Journal of Clinical Oncology

Volumn 5, Issue 3, 2014, Pages 509-519

  Dey, Subhojit ^a  

^a Indian Institute of Public Health Delhi   (India)

Author keywords

Awareness; Breast cancer; Breast self examination; Clinical breast examination; Developing countries; Early detection; Low and middle income countries; Mammography; Screening; Ultrasonography

Indexed keywords

EID: 84939562480     PISSN: None     EISSN: 22184333     Source Type: Journal    
DOI: 10.5306/wjco.v5.i3.509     Document Type: Review

References (133)

1. Ferlay J, Bray F, Pisani P, Parkin DM: GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base No. 5.[1.0]. Lyon, France: IARC, 2001
2. World Bank Country Classifications. Cited on: 2014-03-27. Available from: URL: http://data.worldbank.org/about/country-classifications/country-And-lending-groups
3. Parkin DM, Fernndez LM. Use of statistics to assess the global burden of breast cancer. Breast J 2006; 12 Suppl 1: S70-S80 [PMID: 16430400]
4. Benson JR, Jatoi I. The global breast cancer burden. Future Oncol 2012; 8: 697-702 [PMID: 22764767 DOI: 10.2217/fon.12.61]
5. Shapiro S, Coleman EA, Broeders M, Codd M, de Koning H, Fracheboud J, Moss S, Paci E, Stachenko S, Ballard-Barbash R. Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. International Breast Cancer Screening Network (IBSN) and the European Network of Pilot Projects for Breast Cancer Screening. Int J Epidemiol 1998; 27: 735-742 [PMID: 9839727]
6. International Agency for Research on Cancer: Breast Cancer Screening. Lyon: IARC Press, 2002
7. McCann J, Stockton D, Day N. Breast cancer in East Anglia: the impact of the breast screening programme on stage at diagnosis. J Med Screen 1998; 5: 42-48 [PMID: 9575460]
8. Hakama M, Pukkala E, Heikkil M, Kallio M. Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort study. BMJ 1997; 314: 864-867 [PMID: 9093096]
9. Tabr L, Fagerberg G, Duffy SW, Day NE, Gad A, Grntoft O. Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am 1992; 30: 187-210 [PMID: 1732926]
10. Kricker A, Farac K, Smith D, Sweeny A, McCredie M, Armstrong BK. Breast cancer in New South Wales in 1972-1995: tumor size and the impact of mammographic screening. Int J Cancer 1999; 81: 877-880 [PMID: 10362133]
11. Blanks RG, Moss SM, McGahan CE, Quinn MJ, Babb PJ. Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality. BMJ 2000; 321: 665-669 [PMID: 10987769]
12. World Cancer Report, 2008. Lyon, France: International Agency for Cancer (IARC), 2008
13. Asadzadeh VF, Broeders MJ, Kiemeney LA, Verbeek AL. Opportunity for breast cancer screening in limited resource countries: a literature review and implications for Iran. Asian Pac J Cancer Prev 2011; 12: 2467-2475 [PMID: 22320940]
14. Sankaranarayanan R, Swaminathan R, Brenner H, Chen K, Chia KS, Chen JG, Law SC, Ahn YO, Xiang YB, Yeole BB, Shin HR, Shanta V, Woo ZH, Martin N, Sumitsawan Y, Sriplung H, Barboza AO, Eser S, Nene BM, Suwanrungruang K, Jayalekshmi P, Dikshit R, Wabinga H, Esteban DB, Laudico A, Bhurgri Y, Bah E, Al-Hamdan N. Cancer survival in Africa, Asia, and Central America: a populationbased study. Lancet Oncol 2010; 11: 165-173 [PMID: 20005175 DOI: 10.1016/S1470-2045(09)70335-3]
15. Panieri E. Breast cancer screening in developing countries. Best Pract Res Clin Obstet Gynaecol 2012; 26: 283-290 [PMID: 22222136 DOI: 10.1016/j.bpobgyn.2011.11.007]
16. Lodge M, Corbex M. Establishing an evidence-base for breast cancer control in developing countries. Breast 2011; 20 Suppl 2: S65-S69 [PMID: 21440846 DOI: 10.1016/j.breast.2011.01.012]
17. Sankaranarayanan R, Boffetta P. Research on cancer prevention, detection and management in low-And mediumincome countries. Ann Oncol 2010; 21: 1935-1943 [PMID: 20231304 DOI: 10.1093/annonc/mdq049]
18. IARC Working Group on the Evaluation of Cancer-Preventive Strategies. IARC Handbooks of Cancer Prevention. Vol. 7: Breast Cancer Screening. Lyon, France: IARC Press, 2002
19. Anderson BO, Braun S, Lim S, Smith RA, Taplin S, Thomas DB. Early detection of breast cancer in countries with limited resources. Breast J 2003; 9 Suppl 2: S51-S59 [PMID: 12713497]
20. U.S. Preventive Services Task Force. Screening for breast cancer: recommendations and rationale. Ann Intern Med 2002; 137: 344-346 [PMID: 12204019]
21. ResearchGate question: What are the options for early detection and/or screening for breast cancer in low-And middleincome countries (LMICs)? Available from: URL: https://www.researchgate.net/post/What-Are-The-options-for-e arly-detection-And-or-screening-for-breast-cancer-in-And-middle-income-countries-LMICs
22. Parkin DM. Cancer in developing countries. Cancer Surv 1994; 19-20: 519-561 [PMID: 7534640]
23. Bray F, McCarron P, Parkin DM. The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res 2004; 6: 229-239 [PMID: 15535852]
24. Coleman MP, Esteve J, Dameicki P, Arslan A, Renard H. Trends in Cancer Incidence and Mortality. Lyon: IARC, 1993
25. Pike MC, Krailo MD, Henderson BE, Casagrande JT, Hoel DG. Hormonal risk factors, breast tissue age and the ageincidence of breast cancer. Nature 1983; 303: 767-770 [PMID: 6866078]
26. Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 1975; 15: 617-631 [PMID: 1140864]
27. Dey S, Soliman AS, Merajver SD. Xenoestrogens may be the cause of high and increasing rates of hormone receptor positive breast cancer in the world. Med Hypotheses 2009; 72: 652-656 [PMID: 19155145 DOI: 10.1016/j.mehy.2008.10.025]
28. El Saghir NS. Responding to the challenges of breast cancer in egypt and other arab countries. J Egypt Natl Canc Inst 2008; 20: 309-312 [PMID: 20571588]
29. Anderson BO. Understanding social obstacles to early breast cancer detection is critical to improving breast cancer outcome in low-And middle-resource countries. Cancer 2010; 116: 4436-4439 [PMID: 20572044 DOI: 10.1002/cncr.25361]
30. Harford JB. Breast-cancer early detection in low-income and middle-income countries: do what you can versus one size fits all. Lancet Oncol 2011; 12: 306-312 [PMID: 21376292 DOI: 10.1016/S1470-2045(10)70273-4]
31. Dey S, Boffetta P, Mathews A, Brennan P, Soliman A, Mathew A. Risk factors according to estrogen receptor status of breast cancer patients in Trivandrum, South India. Int J Cancer 2009; 125: 1663-1670 [PMID: 19452528 DOI: 10.1002/ijc.24460]
32. Manjunath S, Prabhu JS, Kaluve R, Correa M, Sridhar TS. Estrogen Receptor Negative Breast Cancer in India: Do We Really Have Higher Burden of this Subtype? Indian J Surg Oncol 2011; 2: 122-125 [PMID: 22693404 DOI: 10.1007/s13193-011-0072-8]
33. Huo D, Ikpatt F, Khramtsov A, Dangou JM, Nanda R, Dignam J, Zhang B, Grushko T, Zhang C, Oluwasola O, Malaka D, Malami S, Odetunde A, Adeoye AO, Iyare F, Falusi A, Perou CM, Olopade OI. Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer. J Clin Oncol 2009; 27: 4515-4521 [PMID: 19704069 DOI: 10.1200/JCO.2008.19.6873]
34. Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002; 137: 347-360 [PMID: 12204020]
35. Swedish Organised Service Screening Evaluation Group. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data. Cancer Epidemiol Biomarkers Prev 2006; 15: 45-51 [PMID: 16434585]
36. Swedish Organised Service Screening Evaluation Group. Effect of mammographic service screening on stage at presentation of breast cancers in Sweden. Cancer 2007; 109: 2205-2212 [PMID: 17471486]
37. Tabr L, Duffy SW, Vitak B, Chen HH, Prevost TC. The natural history of breast carcinoma: what have we learned from screening? Cancer 1999; 86: 449-462 [PMID: 10430253]
38. Erpeldinger S, Fayolle L, Boussageon R, Flori M, Lain X, Moreau A, Gueyffier F. Is there excess mortality in women screened with mammography: a meta-Analysis of nonbreast cancer mortality. Trials 2013; 14: 368 [PMID: 24192052 DOI: 10.1186/1745-6215-14-368]
39. Baum M. The Marmot report: accepting the poisoned chalice. Br J Cancer 2013; 108: 2198-2199 [PMID: 23744283 DOI: 10.1038/bjc.2013.258]
40. Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 2012; 367: 1998-2005 [PMID: 23171096 DOI: 10.1056/NEJMoa1206809]
41. Cutler WB, Burki RE, Kolter J, Chambliss C. Mammography for symptomless women-not so wise? Climacteric 2013; 16: 313-315 [PMID: 23425505 DOI: 10.3109/13697137.2013.77146 3]
42. Wise J. Screening has not reduced deaths from breast cancer, study shows. BMJ 2013; 346: f3780 [PMID: 23757734 DOI: 10.1136/bmj.f3780]
43. Al-Foheidi M, Al-Mansour MM, Ibrahim EM. Breast cancer screening: review of benefits and harms, and recommendations for developing and low-income countries. Med Oncol 2013; 30: 471 [PMID: 23420062 DOI: 10.1007/s12032-013-0471-5]
44. Groot MT, Baltussen R, Uyl-de Groot CA, Anderson BO, Hortobgyi GN. Costs and health effects of breast cancer interventions in epidemiologically different regions of Africa, North America, and Asia. Breast J 2006; 12 Suppl 1: S81-S90 [PMID: 16430401]
45. Okonkwo QL, Draisma G, der Kinderen A, Brown ML, de Koning HJ. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India. J Natl Cancer Inst 2008; 100: 1290-1300 [PMID: 18780864 DOI: 10.1093/jnci/djn292]
46. Yip CH, Smith RA, Anderson BO, Miller AB, Thomas DB, Ang ES, Caffarella RS, Corbex M, Kreps GL, McTiernan A. Guideline implementation for breast healthcare in low-And middle-income countries: early detection resource allocation. Cancer 2008; 113: 2244-2256 [PMID: 18837017 DOI: 10.1002/cncr.23842]
47. International Cancer Screening Network. List of countries with breast cancer screening programs, 2012. Cited on 2014-03-27. Available from: http://appliedresearch.cancer. gov/icsn/breast/screening.html
48. Miller AB. Screening for breast cancer in the Eastern Mediterranean Region. East Mediterr Health J 2010; 16: 1022-1024 [PMID: 21222416]
49. Anderson BO, Cazap E, El Saghir NS, Yip CH, Khaled HM, Otero IV, Adebamowo CA, Badwe RA, Harford JB. Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010. Lancet Oncol 2011; 12: 387-398 [PMID: 21463833 DOI: 10.1016/S1470-2045(11)70031-6]
50. Mittra I, Mishra GA, Singh S, Aranke S, Notani P, Badwe R, Miller AB, Daniel EE, Gupta S, Uplap P, Thakur MH, Ramani S, Kerkar R, Ganesh B, Shastri SS. A cluster randomized, controlled trial of breast and cervix cancer screening in Mumbai, India: methodology and interim results after three rounds of screening. Int J Cancer 2010; 126: 976-984 [PMID: 19697326 DOI: 10.1002/ijc.24840]
51. Boulos S, Gadallah M, Neguib S, Essam E, Youssef A, Costa A, Mittra I, Miller AB. Breast screening in the emerging world: high prevalence of breast cancer in Cairo. Breast 2005; 14: 340-346 [PMID: 16131468]
52. Murillo R, Daz S, Snchez O, Perry F, Pieros M, Poveda C, Salguero E, Osorio D. Pilot Implementation of Breast Cancer Early Detection Programs in Colombia. Breast Care (Basel) 2008; 3: 29-32 [PMID: 20824017]
53. Adib SM, El Saghir NS, Ammar W. Guidelines for breast cancer screening in Lebanon Public Health Communication. J Med Liban 2009; 57: 72-74 [PMID: 19623881]
54. Cohen M, Azaiza F. Increasing breast examinations among arab women using a tailored culture-based intervention. Behav Med 2010; 36: 92-99 [PMID: 20801757 DOI: 10.1080/08 964280903521313]
55. Pisani P, Parkin DM, Ngelangel C, Esteban D, Gibson L, Munson M, Reyes MG, Laudico A. Outcome of screening by clinical examination of the breast in a trial in the Philippines. Int J Cancer 2006; 118: 149-154 [PMID: 16049976]
56. Wu GH, Chen LS, Chang KJ, Hou MF, Chen SC, Liu TJ, Huang CS, Hsu GC, Yu CC, Jeng LL, Chen ST, Chou YH, Wu CY, Shin-Lan K, Chen TH. Evolution of breast cancer screening in countries with intermediate and increasing incidence of breast cancer. J Med Screen 2006; 13 Suppl 1: S23-S27 [PMID: 17227638]
57. Knaul FM, Nigenda G, Lozano R, Arreola-Ornelas H, Langer A, Frenk J. [Breast cancer in Mexico: an urgent priority]. Salud Publica Mex 2009; 51 Suppl 2: s335-s344 [PMID: 19967291]
58. Caleffi M, Ribeiro RA, Bedin AJ, Viegas-Butzke JM, Baldisserotto FD, Skonieski GP, Giacomazzi J, Camey SA, Ashton-Prolla P. Adherence to a breast cancer screening program and its predictors in underserved women in southern Brazil. Cancer Epidemiol Biomarkers Prev 2010; 19: 2673-2679 [PMID: 20716620 DOI: 10.1158/1055-9965.EPI-10-0338]
59. Baig S, Ali TS. Evaluation of efficacy of self breast examination for breast cancer prevention: a cost effective screening tool. Asian Pac J Cancer Prev 2006; 7: 154-156 [PMID: 16629536]
60. Tara S, Agrawal CS, Agrawal A. Validating breast self examination as screening modalities for breast cancer in eastern region of Nepal: a population based study. Kathmandu Univ Med J (KUMJ) 2008; 6: 89-93 [PMID: 18604121]
61. Miller AB. Practical Applications for Clinical Breast Examination (CBE) and Breast Self-Examination (BSE) in Screening and Early Detection of Breast Cancer. Breast Care (Basel) 2008; 3: 17-20 [PMID: 20824015]
62. Mauad EC, Nicolau SM, Moreira LF, Haikel RL, Longatto-Filho A, Baracat EC. Adherence to cervical and breast cancer programs is crucial to improving screening performance. Rural Remote Health 2009; 9: 1241 [PMID: 19778158]
63. Batsis C. Two-stage breast cancer screening in the developing world. World J Surg 2011; 35: 698-699 [PMID: 20857103 DOI: 10.1007/s00268-010-0808-6]
64. Shapiro S, Strax P, Venet L, Venet W. The Health Insurance Plan Project and its Sequelae, 1963-1986. Baltimore: The Johns Hopkins University Press, 1988
65. Miller AB, To T, Baines CJ, Wall C. Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years. J Natl Cancer Inst 2000; 92: 1490-1499 [PMID: 10995804]
66. Rijnsburger AJ, van Oortmarssen GJ, Boer R, Draisma G, To T, Miller AB, de Koning HJ. Mammography benefit in the Canadian National Breast Screening Study-2: a model evaluation. Int J Cancer 2004; 110: 756-762 [PMID: 15146566]
67. Harvey BJ, Miller AB, Baines CJ, Corey PN. Effect of breast self-examination techniques on the risk of death from breast cancer. CMAJ 1997; 157: 1205-1212 [PMID: 9361639]
68. Gastrin G, Miller AB, To T, Aronson KJ, Wall C, Hakama M, Louhivuori K, Pukkala E. Incidence and mortality from breast cancer in the Mama Program for Breast Screening in Finland, 1973-1986. Cancer 1994; 73: 2168-2174 [PMID: 8156521]
69. Thomas DB, Gao DL, Ray RM, Wang WW, Allison CJ, Chen FL, Porter P, Hu YW, Zhao GL, Pan LD, Li W, Wu C, Coriaty Z, Evans I, Lin MG, Stalsberg H, Self SG. Randomized trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst 2002; 94: 1445-1457 [PMID: 12359854]
70. Semiglazov VF, Moiseyenko VM, Bavli JL, Migmanova NSh, Seleznyov NK, Popova RT, Ivanova OA, Orlov AA, Chagunava OA, Barash NJ. The role of breast self-examination in early breast cancer detection (results of the 5-years USSR/WHO randomized study in Leningrad). Eur J Epidemiol 1992; 8: 498-502 [PMID: 1397215]
71. Stapleton JM, Mullan PB, Dey S, Hablas A, Gaafar R, Seifeldin IA, Banerjee M, Soliman AS. Patient-mediated factors predicting early-And late-stage presentation of breast cancer in Egypt. Psychooncology 2011; 20: 532-537 [PMID: 21456061 DOI: 10.1002/pon.1767]
72. Mittra I, Badwe RA, Desai PB, Yeole BB, Jussawalla DJ. Early detection of breast cancer in developing countries. Lancet 1989; 1: 719-720 [PMID: 2564524]
73. Brunner LS, Suddarth DS. Textbook of medical-surgical nursing. Philadelphia: J.B. Lippincott Company, 1988
74. Bhakta P. Asian womens attitudes to breast self-examination. Nurs Times 1995; 91: 44-47 [PMID: 7885907]
75. Huguley CM, Brown RL, Greenberg RS, Clark WS. Breast self-examination and survival from breast cancer. Cancer 1988; 62: 1389-1396 [PMID: 3416278]
76. Singh MM, Devi R, Walia I, Kumar R. Breast self examination for early detection of breast cancer. Indian J Med Sci 1999; 53: 120-126 [PMID: 10798012]
77. Bello M. Awareness is the first step in battle against breast cancer. Bull World Health Organ 2012; 90: 164-165 [PMID: 22461709 DOI: 10.2471/BLT.12.030312]
78. Austoker J, Bankhead C, Forbes LJ, Atkins L, Martin F, Robb K, Wardle J, Ramirez AJ. Interventions to promote cancer awareness and early presentation: systematic review. Br J Cancer 2009; 101 Suppl 2: S31-S39 [PMID: 19956160 DOI: 10.1038/sj.bjc.6605388]
79. Forbes LJ, Linsell L, Atkins L, Burgess C, Tucker L, Omar L, Ramirez AJ. A promoting early presentation intervention increases breast cancer awareness in older women after 2 years: a randomised controlled trial. Br J Cancer 2011; 105: 18-21 [PMID: 21654683 DOI: 10.1038/bjc.2011.205]
80. Ramirez AJ, Westcombe AM, Burgess CC, Sutton S, Little-johns P, Richards MA. Factors predicting delayed presentation of symptomatic breast cancer: a systematic review. Lancet 1999; 353: 1127-1131 [PMID: 10209975]
81. MacDonald S, Macleod U, Mitchell E, Weller D, Campbell N, Mant D. Factors Influencing Patient and Primary Care Delay in the Diagnosis of Cancer Project M0005101440. Glasgow, Scotland: University of Glasgow, Final report to the Department of Health, 2004
82. Harford JB, Edwards BK, Nandakumar A, Ndom P, Capocaccia R, Coleman MP. Cancer control-planning and monitoring population-based systems. Tumori 2009; 95: 568-578 [PMID: 19999948]
83. Frenk J. The shadow epidemic. 2009. Cited on 2014-03-27. Available from: URL: http://www.hsph.harvard.edu/news/magazine/shadow-epidemic/
84. Zelle SG, Baltussen RM. Economic analyses of breast cancer control in low-And middle-income countries: a systematic review. Syst Rev 2013; 2: 20 [PMID: 23566447 DOI: 10.1186/2046-4053-2-20]
85. Anderson BO, Jakesz R. Breast cancer issues in developing countries: an overview of the Breast Health Global Initiative. World J Surg 2008; 32: 2578-2585 [PMID: 18283512 DOI: 10.1007/s00268-007-9454-z]
86. Ginsburg OM. Breast and cervical cancer control in low and middle-income countries: human rights meet sound health policy. J Cancer Pol 2013; 1: e35-e41 [DOI: 10.1016/j.jcpo.2013.07.002]
87. Harirchi I, Mousavi SM, Mohagheghi MA, Mousavi-Jarrahi A, Ebrahimi M, Montazeri A, Rahbar MN. Early detection for breast cancer in iran. Asian Pac J Cancer Prev 2009; 10: 849-851 [PMID: 20104977]
88. Rizwan MM, Saadullah M. Lack of awareness about breast cancer and its screening in developing countries. Indian J Cancer 2009; 46: 252-253 [PMID: 19574687 DOI: 10.4103/0019-509X.52969]
89. Nur N. Breast cancer knowledge and screening behaviors of the female teachers. Women Health 2010; 50: 37-52 [PMID: 20349394 DOI: 10.1080/03630241003601087]
90. Okobia MN, Bunker CH, Okonofua FE, Osime U. Knowledge, attitude and practice of Nigerian women towards breast cancer: a cross-sectional study. World J Surg Oncol 2006; 4: 11 [PMID: 16504034]
91. Karayurt O, Ozmen D, Cetinkaya AC. Awareness of breast cancer risk factors and practice of breast self examination among high school students in Turkey. BMC Public Health 2008; 8: 359 [PMID: 18928520 DOI: 10.1186/1471-2458-8-359]
92. Heidari Z, Mahmoudzadeh-Saheb HR, Sakhavar N. Breast cancer screening knowledge and practice among women in Southeast of Iran. Acta Medica Iranica 2008; 46: 321-328
93. Ibrahim NA, Odusanya OO. Knowledge of risk factors, beliefs and practices of female healthcare professionals towards breast cancer in a tertiary institution in Lagos, Nigeria. BMC Cancer 2009; 9: 76 [PMID: 19261179 DOI: 10.1186/1471-2407-9-76]
94. Akhigbe AO, Omuemu VO. Knowledge, attitudes and practice of breast cancer screening among female health workers in a Nigerian urban city. BMC Cancer 2009; 9: 203 [PMID: 19555506 DOI: 10.1186/1471-2407-9-203]
95. Montazeri A, Vahdaninia M, Harirchi I, Harirchi AM, Sajadian A, Khaleghi F, Ebrahimi M, Haghighat S, Jarvandi S. Breast cancer in Iran: need for greater women awareness of warning signs and effective screening methods. Asia Pac Fam Med 2008; 7: 6 [PMID: 19099595 DOI: 10.1186/1447-056X-7-6]
96. Hatefnia E, Niknami S, Bazargan M, Mahmoodi M, Lamyianm M, Alavi N. Correlates of mammography utilization among working Muslim Iranian women. Health Care Women Int 2010; 31: 499-514 [PMID: 20461601 DOI: 10.1080/0739933 1003725507]
97. Garg P, Bansal M, Garg M, Arora B. Creating awareness about the painless nature of early breast cancer lump is important in low-income countries. Breast J 2010; 16: 101-102 [PMID: 19825004 DOI: 10.1111/j.1524-4741.2009.00847.x]
98. Moshfeghi K, Mohammadbeigi A. Comparison the effects of two educational methods on knowledge, attitude and practices of Arak physicians about breast cancer. Pak J Biol Sci 2010; 13: 901-905 [PMID: 23350164]
99. Noroozi A, Jomand T, Tahmasebi R. Determinants of breast self-examination performance among Iranian women: an application of the health belief model. J Cancer Educ 2011; 26: 365-374 [PMID: 20859775 DOI: 10.1007/s13187-010-0158-y]
100. Dow Meneses K, Yarbro CH. Cultural perspectives of international breast health and breast cancer education. J Nurs Scholarsh 2007; 39: 105-112 [PMID: 17535309]
101. Adib SM, Sabbah MA, Hlais S, Hanna P. Research in action: mammography utilization following breast cancer awareness campaigns in Lebanon 2002-05. East Mediterr Health J 2009; 15: 6-18 [PMID: 19469422]
102. Love RR. Defining a global research agenda for breast cancer. Cancer 2008; 113: 2366-2371 [PMID: 18837032 DOI: 10.1002/cncr.23831]
103. Farmer P. Pathologies of Power. California: University of California Press, 2005
104. Dey S, Soliman AS, Hablas A, Seifeldin IA, Ismail K, Ramadan M, El-Hamzawy H, Wilson ML, Banerjee M, Boffetta P, Harford J, Merajver SD. Urban-rural differences in breast cancer incidence by hormone receptor status across 6 years in Egypt. Breast Cancer Res Treat 2010; 120: 149-160 [PMID: 19548084 DOI: 10.1007/s10549-009-0427-9]
105. Anderson WF, Chatterjee N, Ershler WB, Brawley OW. Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database. Breast Cancer Res Treat 2002; 76: 27-36 [PMID: 12408373]
106. Pegoraro RJ, Karnan V, Nirmul D, Joubert SM. Estrogen and progesterone receptors in breast cancer among women of different racial groups. Cancer Res 1986; 46: 2117-2120 [PMID: 3948183]
107. Uy GB, Laudico AV, Fernandez AM. Immunohistochemical assay of hormone receptors in breast cancer at the Philippine General Hospital: Importance of early fixation of specimens. Philipp J Surg Spec 2007; 62: 123-127
108. Goetz MP, Rae JM, Suman VJ, Safgren SL, Ames MM, Visscher DW, Reynolds C, Couch FJ, Lingle WL, Flockhart DA, Desta Z, Perez EA, Ingle JN. Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes. J Clin Oncol 2005; 23: 9312-9318 [PMID: 16361630]
109. Desta Z, Flockhart DA. Germline pharmacogenetics of tamoxifen response: have we learned enough? J Clin Oncol 2007; 25: 5147-5149 [PMID: 18024859]
110. Leventhal H, Nerenz D, SteeleD. Illness representations and coping with health threats. In: Baum A, Singer J. editors. A Handbook Of Psychology And Health. Erlbaum: Hillsdale, NJ, 1984: 219-252
111. Harford J, Azavedo E, Fischietto M. Guideline implementation for breast healthcare in low-And middle-income countries: breast healthcare program resource allocation. Cancer 2008; 113: 2282-2296 [PMID: 18837020 DOI: 10.1002/cncr.23841]
112. Auerbach AD, Landefeld CS, Shojania KG. The tension between needing to improve care and knowing how to do it. N Engl J Med 2007; 357: 608-613 [PMID: 17687138]
113. Steinbrook R. Closing the affordability gap for drugs in low-income countries. N Engl J Med 2007; 357: 1996-1999 [PMID: 18003957]
114. Bines J, Eniu A. Effective but cost-prohibitive drugs in breast cancer treatment: a clinicians perspective. Cancer 2008; 113: 2353-2358 [PMID: 18837028 DOI: 10.1002/cncr.23837]
115. Cited 2014-03-27. Available from: URL: http://www.who. int/mediacentre/factsheets/fs348/en/index.html
116. Cited 2014-03-27. Available from: URL: http://globocan. iarc.fr/factsheets/cancers/cervix.asp
117. Cited 2014-03-27. Available from: URL: http://globocan. iarc.fr/factsheets/cancers/breast.asp
118. Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol 2012; 13: 790-801 [PMID: 22658655 DOI: 10.1016/S1470-2045(12)70211-5]
119. Farmer P, Frenk J, Knaul FM, Shulman LN, Alleyne G, Armstrong L, Atun R, Blayney D, Chen L, Feachem R, Gospodarowicz M, Gralow J, Gupta S, Langer A, Lob-Levyt J, Neal C, Mbewu A, Mired D, Piot P, Reddy KS, Sachs JD, Sarhan M, Seffrin JR. Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet 2010; 376: 1186-1193 [PMID: 20709386 DOI: 10.1016/S0140-6736(10)61152-X]
120. John R, Ross H. The Global Economic Cost of Cancer. American Cancer Society 2010. Cited 2014-03-27. Available from: URL: http://www.cancer.org/AboutUs/Global-Health/global-economiccost-of-cancer-report
121. Knaul FM, Gralow JR, Atun R, Bhadelia A, editors. Closing the Cancer Divide: An Equity Imperative. Harvard University Press, 2012
122. Cited 2014-03-27. Available from: URL: http://infochangeindia. org/public-health/features/tamil-nadu-pioneerseasy-cervical-cancer-screening.html
123. Akbari ME, Haghighatkhah H, Shafiee M, Akbari A, Bahmanpoor M, Khayamzadeh M. Mammography and ultrasonography reports compared with tissue diagnosis-An evidence based study in Iran, 2010. Asian Pac J Cancer Prev 2012; 13: 1907-1910 [PMID: 22901145]
124. Wang FL, Chen F, Yin H, Xu N, Wu XX, Ma JJ, Gao S, Tang JH, Lu C. Effects of age, breast density and volume on breast cancer diagnosis: a retrospective comparison of sensitivity of mammography and ultrasonography in Chinas rural areas. Asian Pac J Cancer Prev 2013; 14: 2277-2282 [PMID: 23725127]
125. Drukteinis JS, Mooney BP, Flowers CI, Gatenby RA. Beyond mammography: new frontiers in breast cancer screening. Am J Med 2013; 126: 472-479 [PMID: 23561631 DOI: 10.1016/j.amjmed.2012.11.025]
126. Berman CG. Recent advances in breast-specific imaging. Cancer Control 2007; 14: 338-349 [PMID: 17914334]
127. International Telecommunications Union. Measuring the information society (2009). Cited 2014-03-27. Available from: URL: http://www.itu.int/en/ITU-D/Statistics/Documents/facts/ICTFactsFigures2013-e.pdf
128. Internet world stats. Cited 2014-01-27. Available from: URL: http://www.internetworldstats.com/stats.htm
129. Global mobile statistics. Cited 2014-03-27. Available from: URL: http://mobithinking.com/mobile-marketing-tools/latest-mobile-stats/a#subscribers
130. Mechael P. The case for mHealth in developing countries. Innovations, 2009: 103-108
131. Mechael P. Exploring Health-related Uses of Mobile Phones: An Egyptian Case Study. PhD Thesis completed at London School of Hygiene and Tropical Medicine, 2006
132. Lacal J. Cell Phones and telemedicine. Paper presented at the Fifth International Workshop on Enterprise Networking and Computing in the Healthcare Industry. California: Santa Monica, 2003
133. Micevska M. Telecommunications, Public Health, and Demand for Health-Related Information and Infrastructure. Inform Tech Int Dev 2005; 2: 57-72